Oncology
Erlotinib 150mg Erleva 150 Tablet
Non-small cell lung cancer
Prescription onlyTabletAvailable for export
| Product | Erlotinib 150mg Erleva 150 Tablet |
|---|---|
| Used for | Non-small cell lung cancer |
| Dosage form | Tablet |
| Pack | Standard manufacturer pack |
| Manufacturer | Glenmark Pharmaceutical Ltd |
| Composition | Erlotinib (150mg) |
| Strength | 150mg |
| Pack size | 30 Tablets in 1 Bottle |
| Shelf life | 2-3 Years |
| Storage | Store below 30°C, away from light and moisture. |
| Country of origin | India |
Quantityboxes
No payment is taken on this site. We reply with price, batch, expiry and shipping cost. Ask about this product on WhatsApp
Original packsSealed, labelled
Batch documentsInvoice and COA
Tracked shippingDoor delivery
Erlotinib 150mg Erleva 150 Tablet is a tablet in our Oncology range, used for non-small cell lung cancer.
Erlotinib 150mg Tablet is used in the treatment of non-small cell lung cancer and pancreatic cancer.
Hormonal therapy, kinase inhibitors and CDK4/6 inhibitors for breast, prostate, lung, kidney and brain cancers.
This is a prescription medicine and must be used under the supervision of a registered medical practitioner.
